Searched for
PIRAMAL ENTERPRISES EARNINGS
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsFrom a macro perspective, it is clearly a good time to be bullish. But as valuations remain high in parts of the market despite the recent ...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 27% in 1 yearAfter the correction, the street will reach a stage where, if a company delivers numbers, there will be enough money waiting to move into t...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian markets ended higher driven by positive election trends, with gains in financials, pharma, and metals. Nifty held above key support ...
- Piramal Enterprises to make provisions for Rs 3,164 cr AIF exposure as RBI tightens rulesPiramal Enterprises has announced a provision of over Rs 3,000 crore for its investments in alternative investment funds (AIFs) linked to c...
- Piramal Enterprises Q1 Results: Co reports Rs 509 cr profit on Shriram stake saleTotal assets of the company rose to Rs 63,938 crore, of which retail loans constituted 55%, up from 34% a year ago. Retail loans grew 57% t...
- Piramal Ent posts Rs 1,536-cr loss in Q2 on high provisionsThe lender's gross non-performing assets ratio stood at 3.7% at the end of September with the net NPA ratio being at 1.3%. Its assets under...
- Piramal Enterprises Q1 Results: Profit down but retail growth strongOverall the company's assets under management (AUM) grew 37% to Rs 64,590 crore led by a four times growth in retail loans to Rs 22,267 cro...
- Piramal Enterprises Q4 Results: Firm posts profit of Rs 151 cr vs loss of Rs 510 croreFor the whole financial year 2021-22, it reported a 41 per cent jump in the net profit at around Rs 2,000 crore, it said in a release. Duri...
- Piramal Enterprise gets board nod for demerger and listing of pharma businessThe pharmaceuticals business will get vertically demerged from Piramal Enterprises and consolidated under Piramal Pharma Ltd (PPL), the gro...
- Piramal Pharma completes acquisition of Hemmo PharmaceuticalsIn March this year, Piramal Pharma Ltd entered into an agreement to acquire a 100 per cent stake in Hemmo Pharmaceuticals for an upfront co...
- Piramal Enterprises Q1 net up 21% at Rs 461 croreThe company had reported a net profit of Rs 382 crore in the year-ago period.
- What Piramal’s stake sale in STFC tells us about NBFCsThe development does not affect the fundamentals of STFC much in the medium term.
- Piramal Enterprises Q4 profit dives 88% to Rs 456 croreConsolidated revenue from operations stood at Rs 3,679.67 crore.
- Piramal Enterprises posts 23% rise in Q3 net profitShares of the company fell 5.85 per cent to Rs 2,162 on the BSE.
- Piramal refutes rumours of loan default by Lodha, Vatika, othersThe company said it has no debt exposure to developers like Aristo, Nahar, Supertech, Radius and Amrapali.
- Ajay Piramal eyes $1 billion in contract pharma saleDeliberations are at an early stage, and Piramal Enterprises could still decide against pursuing a deal, the people said.
- Piramal Enterprises to buy 5 Janssen drugs for Rs 1,164 croreThe transaction, which is expected to close this week, marks the Ajay Piramal-led company’s sixth deal in the healthcare space in the past ...
- Piramal to buy select injectable brands from Janssen for up to $175 millionPiramal will pay an upfront cash of $155 million and the rest on meeting certain sales-related milestones, a press release said.
- Piramal Enterprises to acquire Ash Stevens Inc for more than Rs 350 crore"Ash Stevens will add high potency capabilities to the services we offer our customers," Vivek Sharma, Pharma Solutions business CEO, Piram...
- Piramal Enterprises posts Q1 net profit of Rs 202.74 croreConsolidated total income from operations of the company stood at Rs 1,473.59 crore during the quarter under consideration.
Load More
